This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jan;44(1 Suppl 1):S1-3.

doi: 10.1053/j.seminhematol.2006.12.001.

Introduction: chronic myelogenous leukemia (CML)

Elias Jabbour¹, Hagop Kantarjian

Affiliations

PMID: 17292735
DOI: 10.1053/j.seminhematol.2006.12.001

Editorial

Introduction: chronic myelogenous leukemia (CML)

Elias Jabbour et al. Semin Hematol. 2007 Jan.

. 2007 Jan;44(1 Suppl 1):S1-3.

doi: 10.1053/j.seminhematol.2006.12.001.

Authors

Elias Jabbour¹, Hagop Kantarjian

Affiliation

¹ Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

PMID: 17292735
DOI: 10.1053/j.seminhematol.2006.12.001

No abstract available

PubMed Disclaimer

Similar articles

Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
Druker BJ. Druker BJ. Oncogene. 2002 Dec 9;21(56):8541-6. doi: 10.1038/sj.onc.1206081. Oncogene. 2002. PMID: 12476300 Review. No abstract available.
Update on the use of imatinib mesylate.
Sawyers CL. Sawyers CL. Clin Adv Hematol Oncol. 2005 Oct;3(10):757-8. Clin Adv Hematol Oncol. 2005. PMID: 16258483 No abstract available.
Treating cancer's kinase 'addiction'.
Baselga J, Arribas J. Baselga J, et al. Nat Med. 2004 Aug;10(8):786-7. doi: 10.1038/nm0804-786. Nat Med. 2004. PMID: 15286778 No abstract available.
New-age drug meets resistance.
McCormick F. McCormick F. Nature. 2001 Jul 19;412(6844):281-2. doi: 10.1038/35085665. Nature. 2001. PMID: 11460142 No abstract available.
Resistance and relapse with imatinib in CML: causes and consequences.
Deininger M. Deininger M. J Natl Compr Canc Netw. 2008 Mar;6 Suppl 2:S11-S21. J Natl Compr Canc Netw. 2008. PMID: 18397677 Review.

See all similar articles

Cited by

Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
Luatti S, Baldazzi C, Marzocchi G, Ameli G, Bochicchio MT, Soverini S, Castagnetti F, Tiribelli M, Gugliotta G, Martinelli G, Baccarani M, Cavo M, Rosti G, Testoni N. Luatti S, et al. Oncotarget. 2017 May 2;8(18):29906-29913. doi: 10.18632/oncotarget.15369. Oncotarget. 2017. PMID: 28404889 Free PMC article.
Reliability Evaluation of Fluorescence In Situ Hybridization (FISH) and G-Banding on Bone Marrow and Peripheral Blood Cells in Chronic Myelogenous Leukemia Patients.
Manaflouyan Khajehmarjany S, Rahmani SA, Chavoshi SH, Esfahani A, Movassaghpour Akbari AA. Manaflouyan Khajehmarjany S, et al. Cell J. 2015 Spring;17(1):171-80. doi: 10.22074/cellj.2015.525. Epub 2015 Apr 8. Cell J. 2015. PMID: 25870848 Free PMC article.
Chronic Myeloid Leukemia with b3a3 (e14a3) Fusion: A Rare BCR/ABL Rearrangement Presenting with Thrombocytosis - Does MTHFR Polymorphism Matter.
Chisti MM, Sanders DS. Chisti MM, et al. Case Rep Oncol. 2018 Jul 16;11(2):485-492. doi: 10.1159/000490697. eCollection 2018 May-Aug. Case Rep Oncol. 2018. PMID: 30140211 Free PMC article.
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R; European LeukemiaNet. Baccarani M, et al. J Clin Oncol. 2009 Dec 10;27(35):6041-51. doi: 10.1200/JCO.2009.25.0779. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884523 Free PMC article. Review.
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.
Lang F, Wunderle L, Pfeifer H, Schnittger S, Bug G, Ottmann OG. Lang F, et al. Am J Case Rep. 2017 Oct 16;18:1099-1109. doi: 10.12659/ajcr.904956. Am J Case Rep. 2017. PMID: 29033451 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information